Third dose Pfizer vaccine, Ema: off to question examination

Third dose of the Pfizer vaccine, the EMA starts the process. The European Medicines Agency has “started evaluating an application for the use of a booster dose of Comirnaty”, Pfizer / BioNTech’s anti-Covid vaccine, “to be administered 6 months after the second dose to people of equal age. or over 16 years “. This was announced by the EU regulatory body, underlining that “separately” it is also “evaluating the literature data on the use of a third additional dose of an mRna vaccine – Comirnaty or SpikeVax (the product of Moderna, ed) – in seriously ill people immunocompromised “.